Health copyright instructed the Star it's got contacted Adastra to “reiterate the extremely slender parameters of their licence.” The company subsequently issued a next launch Friday retracting what it mentioned in its first statement and noting: “This kind of statements shouldn't be relied on.”“We'll evaluate how the commercialization of